- Home
- WNEB vs AMRN Comparison
WNEB vs AMRN Comparison
Compare WNEB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- AMRN
- Stock Information
- Founded
- WNEB 1853
- AMRN 1989
- Country
- WNEB United States
- AMRN Ireland
- Employees
- WNEB N/A
- AMRN N/A
- Industry
- WNEB Savings Institutions
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WNEB Finance
- AMRN Health Care
- Exchange
- WNEB Nasdaq
- AMRN Nasdaq
- Market Cap
- WNEB 191.1M
- AMRN 189.2M
- IPO Year
- WNEB N/A
- AMRN 1993
- Fundamental
- Price
- WNEB $9.42
- AMRN $0.55
- Analyst Decision
- WNEB Buy
- AMRN Buy
- Analyst Count
- WNEB 3
- AMRN 1
- Target Price
- WNEB $9.75
- AMRN N/A
- AVG Volume (30 Days)
- WNEB 48.1K
- AMRN 1.1M
- Earning Date
- WNEB 01-28-2025
- AMRN 02-27-2025
- Dividend Yield
- WNEB 3.00%
- AMRN N/A
- EPS Growth
- WNEB N/A
- AMRN N/A
- EPS
- WNEB 0.56
- AMRN N/A
- Revenue
- WNEB $73,385,000.00
- AMRN $241,021,000.00
- Revenue This Year
- WNEB N/A
- AMRN N/A
- Revenue Next Year
- WNEB $10.26
- AMRN N/A
- P/E Ratio
- WNEB $16.73
- AMRN N/A
- Revenue Growth
- WNEB N/A
- AMRN N/A
- 52 Week Low
- WNEB $6.00
- AMRN $0.43
- 52 Week High
- WNEB $10.08
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- WNEB 58.60
- AMRN 50.48
- Support Level
- WNEB $9.25
- AMRN $0.55
- Resistance Level
- WNEB $9.47
- AMRN $0.61
- Average True Range (ATR)
- WNEB 0.16
- AMRN 0.04
- MACD
- WNEB 0.06
- AMRN -0.00
- Stochastic Oscillator
- WNEB 76.71
- AMRN 26.56
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.